Compliance Essentials: Data-Driven HCP Engagements
July 5, 2024
Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
Putting outlook toward pre-CMS submission analytics to the test, qordata conducted a poll during its webinar earlier this month. The question was: “How important are analytics for reviewing spend prior to submission?” The results were unsurprising: 63% of participants believed using analytics prior to CMS submission was “Very Important,” with another 31% saying it was […]
The landscape for Pharmaceutical Drug and Device Manufacturers in North America is changing, especially after the ratification of the Sunshine Payments Act. There’s more publicly available data for everyone—over 25 million records and counting—and much more public accountability accompanying it. Instead of waiting for competitors, the media, Public Prosecutors, or Civil Interest Groups to arrive at […]
There comes a point in life when one comes under the umbrella of rules and regulations. At times, these regulations don’t seem to add much benefit and, in a way, restrict activity unless an individual or an organization is ready to harness this change into something beneficial. The pharmaceutical industry is on the verge of […]
Zurich, Switzerland: Mohammad Ovais, CEO and Founder of qordata, was one of the keynote speakers at the 5th Annual Corporate Compliance & Transparency Conference in the Pharmaceutical Industry. In his address, Mr. Ovais described how qordata, one of the foremost providers of a SaaS Solution for Pharmaceutical Compliance, Business Intelligence, and HCP/HCO Engagement, has identified […]
Both the U.S. and global transparency requirements call for Life Sciences companies to fulfill certain transaction-level reporting criteria. These requirements include the Sunshine Act, U.S. state laws, and European laws. All of these deem it necessary for transfers of value made by pharma companies to physicians to be tracked and reported to the authorities. The […]
A major concern for pharma manufacturers in the EU when submitting their spend is that of duplication of data. The reason behind this concern is that of the risk it poses to their reputation and relationship with HCPs. However, duplication of data can be avoided by verifying it with HCPs before making the data public. In […]
Complete the form below and our business team will be in touch to schedule a product demo.
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use